Made with ❤️ by True Sparrow

Bringing you the latest funding data

SENISCA

Last funding round

Raised
$4,700,000
Round
Unknown

Funding News (2)

Mar 18 2024BioSpace

Startup details

SENISCA

SENISCA

SENISCA is an award-winning biotechnology company focused on modulating RNA biology to treat age-related diseases. The company has developed a proprietary technology that harnesses RNA biology to reprogram aged 'senescent' cells, targeting multiple age-related diseases including those of the eyes, lungs, joints, and brain.
www.senisca.com
Exeter, Devon, United Kingdom
Established in 2020
11-50 People
Healthcare, Therapeutics

Founders

Dr. Sarah Cole

Dr. Sarah Cole

CEO

Ex: TranSINE Therapeutics, Takeda Ventures, Inc. (TVI), Takeda Cambridge Neuroscience, Takeda Cambridge, Northwestern University, Feinberg School of Medicine, Northwestern University, GlaxoSmithKline, GIAP, SmithKline Beecham

Cambridge, England, United Kingdom

Investment details

Total Funding
$9,000,000
Raised
$4,700,000
Round
Unknown
Investors
Apex Ventures
QantX
Emerging Longevity Ventures
R42 Group
Lifespan Vision Ventures

Funding News (1)

Mar 18 2024FinSMEs

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

Jul2024
1

3 weeks ago

Natcap raised a $10M Series A from Norinchukin Bank and 6 others
UK-based Natcap provides nature data for assessing risks and opportunities in corporate reporting.
Natcap

Founders

Kathy Willis

In News

Carbon Pulse
2

3 weeks ago

Altrove raised a $4M Pre-Seed led by Contrarian Ventures
London-based Altrove develops sustainable alternatives to critical earth materials.
Altrove

Founders

Thibaud Martin,

Dr. Joonatan Laulainen

In News

Tech.eu
Tech Funding News
Yahoo Tech
StartupNews.fyi
3

3 weeks ago

TaperedPlus raised $7M from Comhar Capital
UK-based TaperedPlus specializes in tech-enabled architectural design services for flat and tapered roof projects.
TaperedPlus

Founders

Robert Vass,

Aman Chahal

In News

Business Up North
4

3 weeks ago

Beacon Therapeutics raised a $170M Series B led by Forbion and 1 other
London-based Beacon Therapeutics develops gene therapies for blinding retinal diseases.
Beacon Therapeutics

Founders

David Fellows

In News

NewsnReleases
DirectorsTalk Interviews
5

3 weeks ago

Trever raised a $2.6M Seed led by TX Ventures and 1 other
Europe-based Trever provides infrastructure for digital asset management to financial institutions.
Trever

Founders

Hans-Jürgen Griesbacher

In News

Tech.eu
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.